This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Ashtead (full-year earnings 19 June)
Ashtead’s prominence in the US continues to be a boon for the firm thanks to the strong economic growth in America, and its push to acquire more market share should boost returns further. Cash flows have continued to rise, and while for now the extra money is being used for expansion, it could be cut back if debt starts to become too much of a burden. A weaker dollar of late has borne down on performance, but that has become less of a concern over the past couple of months. Meanwhile, at 13.5 times earnings the shares are not too excessively valued. Ashtead is expected to report earnings of £1.31 per share, up 26% over the year, and revenue of £3.67 billion, up 15%.
Once again there seems no stopping Ashtead. The price has consolidated in the £23-£24 range, and looks set to push above its recent high at £24.41. Near-term support comes in at £22.85, with £21.84 below this. Any serious weakness would still represent a buying opportunity.